Beacon Investment Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $267K | Sell |
|
|||||
|
2025
Q2 | $421K | Sell |
|
|||||
|
2025
Q1 | $456K | Sell |
|
|||||
|
2024
Q4 | $876K | Sell |
|
|||||
|
2024
Q3 | $1.21M | Sell |
|
|||||
|
2024
Q2 | $1.13M | Sell |
|
|||||
|
2024
Q1 | $750K | Sell |
|
|||||
|
2023
Q4 | $1.04M | Sell |
|
|||||
|
2023
Q3 | $1.26M | Sell |
|
|||||
|
2023
Q2 | $1.93M | Sell |
|
|||||
|
2023
Q1 | $2.09M | Sell |
|
|||||
|
2022
Q4 | $2.53M | Sell |
|
|||||
|
2022
Q3 | $2.14M | Sell |
|
|||||
|
2022
Q2 | $1.59M | Sell |
|
|||||
|
2022
Q1 | $1.79M | Sell |
|
|||||
|
2021
Q4 | $1.87M | Buy |
|
|||||
|
2021
Q3 | $1.75M | Buy |
|
|||||
|
2021
Q2 | $1.51M | Buy |
|
|||||
|
2021
Q1 | $1.18M | Buy |
|
|||||
|
2020
Q4 | $589K | Buy |
|